Situation:  Pre-COVID, patients being prescribed controlled substances required at least one in-person visit pursuant to the Ryan Haight Act.  The DEA temporarily waived the in-person requirement during the COVID public health emergency so as to prevent lapses in care for those being prescribed medications such as Suboxone for opioid use disorder.  In May 2023…